X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (666) 666
Publication (56) 56
Book Review (11) 11
Newsletter (5) 5
Book Chapter (3) 3
Newspaper Article (3) 3
Book / eBook (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (493) 493
mucopolysaccharidosis (388) 388
index medicus (376) 376
male (292) 292
female (271) 271
child (238) 238
enzymes (207) 207
enzyme replacement therapy (201) 201
child, preschool (194) 194
genetics & heredity (181) 181
pediatrics (176) 176
adolescent (163) 163
children (144) 144
adult (138) 138
disease (124) 124
medicine, research & experimental (124) 124
glycosaminoglycans (121) 121
care and treatment (109) 109
infant (105) 105
bone-marrow-transplantation (100) 100
health aspects (98) 98
animals (96) 96
transplantation (94) 94
diagnosis (93) 93
endocrinology & metabolism (88) 88
enzyme-replacement therapy (80) 80
analysis (79) 79
mucopolysaccharidosis iii - complications (79) 79
mucopolysaccharidoses - complications (78) 78
young adult (74) 74
mucopolysaccharidoses (72) 72
research (68) 68
lysosomal storage diseases (67) 67
medicine (67) 67
medicine & public health (65) 65
treatment outcome (61) 61
hurler-syndrome (58) 58
hematopoietic stem cells (55) 55
genetics (54) 54
internal medicine (54) 54
mutation (52) 52
hematopoietic stem cell transplantation (51) 51
mice (50) 50
patients (50) 50
gene therapy (49) 49
mucopolysaccharidoses - therapy (49) 49
phenotype (49) 49
glycosaminoglycans - metabolism (48) 48
mucopolysaccharidosis i - complications (48) 48
retrospective studies (48) 48
article (47) 47
lysosomal storage disorders (46) 46
stem cells (46) 46
stem-cell transplantation (44) 44
lysosomal storage disease (43) 43
mucopolysaccharidosis i - therapy (43) 43
age (42) 42
hunter syndrome (42) 42
heparan sulfate (41) 41
metabolic diseases (40) 40
maroteaux-lamy-syndrome (39) 39
risk factors (39) 39
biochemistry, general (38) 38
disease models, animal (38) 38
sulfates (38) 38
congenital, hereditary, and neonatal diseases and abnormalities (37) 37
genetic aspects (37) 37
medical research (37) 37
clinical neurology (36) 36
complications and side effects (36) 36
management (36) 36
mucopolysaccharidoses - diagnosis (36) 36
pharmacology & pharmacy (36) 36
review (36) 36
biochemistry & molecular biology (35) 35
development and progression (35) 35
enzyme replacement therapy - methods (35) 35
human genetics (35) 35
hurler syndrome (34) 34
medicine, experimental (34) 34
mucopolysaccharidosis ii - complications (34) 34
mouse model (33) 33
nutritional and metabolic diseases (33) 33
brain (32) 32
middle aged (32) 32
mucopolysaccharidosis iii - pathology (32) 32
radiography (32) 32
disorders (31) 31
neurosciences (31) 31
physiological aspects (31) 31
sanfilippo-syndrome (31) 31
follow-up studies (30) 30
hunter-syndrome (30) 30
sanfilippo syndrome (30) 30
therapy (30) 30
usage (30) 30
hematology (29) 29
magnetic resonance imaging (28) 28
metabolic disorders (28) 28
surgery (28) 28
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (652) 652
French (10) 10
German (4) 4
Spanish (4) 4
Turkish (3) 3
Italian (2) 2
Polish (2) 2
Portuguese (2) 2
Dutch (1) 1
Japanese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brain, ISSN 0006-8950, 02/2015, Volume 138, Issue 2, pp. 336 - 355
Journal Article
Pediatric Anesthesia, ISSN 1155-5645, 08/2012, Volume 22, Issue 8, pp. 737 - 744
Journal Article
Pediatric Pulmonology, ISSN 8755-6863, 03/2014, Volume 49, Issue 3, pp. 277 - 284
Background The mucopolysaccharidoses (MPS) comprise a group of inherited lysosomal storage disorders characterized by deficiencies in enzymes catalyzing the... 
glycosaminoglycans | pulmonary function | enzyme replacement therapy | spirometry | mucopolysaccharidoses | MORTALITY | LARONIDASE | EQUATIONS | CHINESE CHILDREN | HONG-KONG | REFERENCE VALUES | RESPIRATORY SYSTEM | PEDIATRICS | Spirometry | Age Factors | Mucopolysaccharidosis IV - complications | Humans | Mucopolysaccharidosis I - physiopathology | Mucopolysaccharidosis VI - complications | Male | Mucopolysaccharidosis III - drug therapy | Lung Diseases - etiology | Forced Expiratory Volume | Young Adult | Mucopolysaccharidosis II - physiopathology | Adult | Female | Mucopolysaccharidoses - complications | Mucopolysaccharidosis VI - drug therapy | Child | Mucopolysaccharidosis VI - physiopathology | Mucopolysaccharidoses - drug therapy | Severity of Illness Index | Mucopolysaccharidoses - physiopathology | Mucopolysaccharidosis III - physiopathology | Treatment Outcome | Lung - physiopathology | Mucopolysaccharidosis IV - drug therapy | Disease Progression | Mucopolysaccharidosis I - complications | Lung Diseases, Obstructive - physiopathology | Mucopolysaccharidosis III - complications | Enzyme Replacement Therapy - methods | Mucopolysaccharidosis II - complications | Mucopolysaccharidosis IV - physiopathology | Mucopolysaccharidosis II - drug therapy | Mucopolysaccharidosis I - drug therapy | Vital Capacity - physiology | Adolescent | Lung Diseases, Obstructive - etiology | Lung Diseases - physiopathology | Respiratory Function Tests | Peak Expiratory Flow Rate | Maximal Midexpiratory Flow Rate | Enzymes | Respiratory tract diseases | Care and treatment | Mucopolysaccharidosis | Glycosaminoglycans | Chemical properties
Journal Article
Journal Article
Pediatrics, ISSN 0031-4005, 09/2014, Volume 134, Issue 3, pp. e884 - e888
Journal Article